DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

Amgen 

Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010


SEARCH JOBS

View Clinical Trials from BioPharm Insight





Collaborations

Genesis Research and Development Corporation 

Phylos, Inc.  In 2000, Phylos entered into collaboration with Amgen to apply Phylos' PROfusion™ technology to rapidly identify high-affinity binding agents to potential therapeutic targets supplied by Amgen. Amgen will use the sequences and structural information gained through this collaboration for its internal drug discovery programs.

UCB, Inc.  Contract manufacturing of Abarelix peptide active ingredient

EPIX Pharmaceuticals, Inc. 

Dyax Corp.  Antibody phage display





 Company News
Amgen (AMGN), Bristol-Myers Squibb Company (BMY) On The Prowl For Space In Crowded Cambridge, Massachusetts 8/19/2014 10:02:02 AM
Good News For Amgen (AMGN) As Parathyroid Drug AMG 416 Succeeds In Phase 3 Study 8/18/2014 3:58:43 PM
Amgen (AMGN) Recalls Nine Packaged Lots Of Aranesp 8/13/2014 4:16:18 PM
Amgen (AMGN) Drops After Hours On Failed Phase 3 Multiple Myeloma Trial 8/13/2014 4:14:02 PM
Trial A Success, Amgen (AMGN) CEO Doesn't Have To Quit 8/5/2014 6:00:19 AM
Blow To Amgen (AMGN)'s Profits As Express Scripts Inc. Drops Drugs From List Of Preferred Drugs 8/4/2014 6:08:21 AM
Amgen (AMGN) Drug Kyprolis Helped Patients Live 8.7 Months Longer In Late-Stage Trial 8/4/2014 5:53:58 AM
Amid Cuts, Amgen (AMGN) To Add Jobs In Cambridge, Massachusetts 7/30/2014 11:28:42 AM
Amgen (AMGN)'s Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (Eps) Increased 25 Percent To $2.37 7/30/2014 9:05:48 AM
Three Things To Take Away From Amgen (AMGN)'s Big Restructuring 7/30/2014 6:33:50 AM
12345678910...